About Us
Hemolab is a family-owned group based in Casablanca, Morocco, operating in crucial healthcare sectors (pharmaceuticals, medical devices, medical diagnostics) and water. In partnership with international players, the Hemolab group provides relevant technologies tailored to the specific needs of the market.
Hemolab is structured as follows:
- Pharmaceutical sector - Hemolab Pharma
- Medical devices - Hemolab MD
- Medical diagnostics - Hemolab DX
- Water - Hemolab Water
Mission
To contribute to saving and sustaining lives through innovative and robust technologies.
Vision
To be an essential, competent, and recognized local and regional player.
Values
ENTREPRENEURSHIP
PERSEVERANCE
HUMILITY
INTEGRITY
RESPECT
TEAM
History
Hemolab is a pioneer in hemodialysis in Morocco established in 1994. It diversified its activities in 1995 with Hemolab Pharma, becoming the first manufacturer of hemodialysis concentrate in the country. The acquisition of SPMCP in 2000 strengthened its position in the medical devices segment. Since then, the group has expanded to cover anaesthesia, resuscitation, oncology, biopharmaceuticals, diagnostics and water.
News
Moroccan Society of Nephrology 2024 Congress (SMN)
We are pleased to share with you HEMOLAB's participation in the 20th National Congress of the Moroccan Society of Nephrology, held from April 25th to 27th, 2024, at the Bouregreg Congress Palace in Rabat. We would like to extend our thanks to the Moroccan Society of Nephrology for the success of this event. We also wish to express our gratitude to all nephrologists who visited our booth to celebrate the 30th anniversary of the HEMOLAB Group. Our team remains at your disposal for any information request.
Nous tenons à adresser nos remerciements à la Société Marocaine de Néphrologie pour le succès de cet événement.
Nous souhaitons également exprimer notre gratitude à tous les néphrologues qui ont visité notre stand pour célébrer les 30 ans du Groupe HEMOLAB.
Notre équipe se tient à votre entière disposition pour toute demande d’information.
Annual Meeting of the Syndicate Chamber of Biologists 2024
Participation of HEMOLAB Dx at the 2nd edition of the annual meetings of the Syndicate Chamber of Biologists, held from February 1st to 3rd, 2024, at the Hyatt Regency in Casablanca.
Congress SMAAR 2023 (Moroccan Society of Anesthesia, Analgesia, and Resuscitation)
Our participation in the 35th edition of the Congress of the Moroccan Society of Anesthesia, Analgesia, and Resuscitation (SMAAR) in Marrakech from December 14th to 16th, 2023, included a highly appreciated symposium titled "Why ? When and how to use fibrinogen in postpartum hemorrhage ?", led by one of our partnering physicians.
Kidney Transplantation Day in 2022
We participated in the Kidney Transplantation Day in 2022 in Marrakech, where we had the pleasure of presenting the Luminex solution and the Immucor range to participants.
MAARC Congress (Moroccan Association of Anaesthesiologists and ICU physicians of Casablanca)
An annual regional conference primarily gathering anaesthesiologists and ICU physicians from Casablanca, which took place on March 10th and 11th, 2023, at the Hayatt Regency hotel. The theme for this event was perioperative medicine.
MSN Congress (Moroccan Society of Nephrology)
We were delighted to participate in the 19th National Nephrology Congress from March 2nd to 4th, 2023, at the Paradise Club in Casablanca. It was a pleasure to meet our valued nephrologist partners, many of whom visited our booth to observe demonstrations of our unique DBB EXA hemodialysis machines.
Congress SMAAR 2022 (Moroccan Society of Anesthesia, Analgesia, and Resuscitation)
Our commitment to the 34th edition of the Moroccan Society of Anaesthesia, Analgesia, and Resuscitation (SMAAR) Congress in Marrakech from December 22nd to 24th, 2022, included a successful workshop titled 'Hemosims' on polytrauma emergencies, conducted by one of our partnering physicians.
Partnership
Our partnerships have lasted for several decades, characterized by success resulting from strong synergies in terms of portfolio and channel.
These collaborations are meticulously studied, pre-planned, and executed methodically.